Publication | Open Access

Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis

InflammationAnti-inflammatoryHealth SciencesAfrican TrypanosomiasisMedicineLiver PhysiologyImmunologyInflammatory ResponseCell DeathPathologyHepatotoxicityPharmacotherapyPharmacologyDrug-induced Liver InjuryTrypanocidal DrugChagas DiseaseDrug Resistance